Lixte Biotechnology Holdings, Inc.
LIXT
$3.45
$0.164.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.93% | 33.27% | -36.55% | -36.90% | -23.99% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.85% | 21.48% | 107.80% | -29.14% | -25.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -34.63% | 32.19% | -32.18% | -36.68% | -25.68% |
|
|
|||||
| Total Current Assets | -34.63% | 32.19% | -32.18% | -36.68% | -25.68% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -21.50% | 32.19% | -32.45% | -36.43% | -25.68% |
|
|
|||||
| Total Accounts Payable | -27.02% | 101.97% | -23.59% | -44.52% | -36.80% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 83.43% | 3.19% | -8.20% | -11.72% | 34.24% |
| Total Other Current Liabilities | 83.43% | 3.19% | -8.20% | -11.72% | 34.24% |
| Total Current Liabilities | 51.25% | 11.56% | -3.25% | -21.95% | -8.92% |
|
|
|||||
| Total Current Liabilities | 51.25% | 11.56% | -3.25% | -21.95% | -8.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 51.25% | 11.56% | -3.25% | -21.95% | -8.92% |
|
|
|||||
| Common Stock & APIC | 7.47% | 2.11% | 0.16% | 0.22% | 0.27% |
| Retained Earnings | -1.47% | -1.36% | -1.20% | -1.95% | -2.04% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 127.83% | 12.42% | -25.30% | -70.12% | -235.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 127.83% | 12.42% | -25.30% | -70.12% | -235.63% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -43.79% | 40.12% | -39.48% | -39.14% | -28.16% |
|
|
|||||